Cost-effectiveness analysis of magnetic resonance imaging-conditional pacemaker implantation: Insights from a multicenter study and implications in the current era

Heart Rhythm. 2018 Nov;15(11):1690-1697. doi: 10.1016/j.hrthm.2018.05.024. Epub 2018 May 24.

Abstract

Background: Magnetic resonance imaging (MRI)-conditional pacemakers (M-PPMs) grant patients greater accessibility to MRI scans. The cost-effectiveness of implanting M-PPM is unknown.

Objective: The purpose of this study was to determine the cost-effectiveness of M-PPM implantation.

Methods: Cost-effectiveness analysis was performed on patients receiving a M-PPM across 4 institutions. The incremental cost-effectiveness ratio (ICER) was calculated by dividing the sum of the total incremental cost of implanting a M-PPM vs a conventional pacemaker and the cost of MRI scans by the utility of MRI scans in terms of quality-adjusted life-years (QALY) gained. QALY and lifespan of M-PPM (7-11 years) data were obtained from the literature. The benchmark of <$100,000 per QALY was used as the threshold for cost-effectiveness. Computer modeling/simulations were used to calculate the percentage of patients required to achieve this benchmark, to extrapolate the cumulative projected percentage of patients utilizing MRI scans over the lifespan of a M-PPM via the Weibull parametric survival model, and to conduct univariate and multivariate, probabilistic sensitivity analyses.

Results: The ICER during the follow-up period (21 ± 17 months) was $451,569. The cost-effectiveness ICER benchmark is reached 7.0 years postimplantation, when a projected 38% of recipients would receive MRI scans. The projected percentage of patients receiving MRI scans at 11 years was 58%, yielding an ICER of $74,221 per QALY. Henceforth, assuming increased MRI usage in regular PPM based on Centers for Medicare & Medicaid Services memo CAG00399R4 and decreased cost of M-PPM, M-PPM implantation is still cost-effective, with a lifetime ICER of $49,817 per QALY.

Conclusion: M-PPM implantation is cost-effective over the lifespan of a M-PPM based on projected usage of MRI.

Keywords: Cost-effectiveness analysis; Magnetic resonance imaging; Magnetic resonance imaging–conditional pacemaker; Pacemaker; Quality-adjusted life-years.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Cost-Benefit Analysis
  • Female
  • Follow-Up Studies
  • Heart Failure / economics
  • Heart Failure / therapy*
  • Humans
  • Magnetic Resonance Imaging, Cine / economics*
  • Magnetic Resonance Imaging, Cine / methods
  • Male
  • Models, Economic*
  • Pacemaker, Artificial*
  • Quality-Adjusted Life Years*
  • Retrospective Studies
  • Surgery, Computer-Assisted / economics*
  • Treatment Outcome
  • United States